adefovir has been researched along with dobutamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cui, X; Eichacker, PQ; Fitz, Y; Hicks, CW; Leppla, SH; Li, Y; Mignone, TS; Moayeri, M; Mohanty, A; Okugawa, S; Solomon, SB; Subramanian, GM | 1 |
1 review(s) available for adefovir and dobutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for adefovir and dobutamine
| Article | Year |
|---|---|
Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.
Topics: Adenine; Adrenergic beta-1 Receptor Agonists; Animals; Antigens, Bacterial; Bacterial Toxins; Cyclic AMP; Dobutamine; Heart; Heart Rate; Male; Myocardium; Organophosphonates; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2011 |